These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 19691467)

  • 41. Impact of novel mutations of herpes simplex virus 1 and 2 thymidine kinases on acyclovir phosphorylation activity.
    Burrel S; Bonnafous P; Hubacek P; Agut H; Boutolleau D
    Antiviral Res; 2012 Dec; 96(3):386-90. PubMed ID: 23041200
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis.
    van Velzen M; van de Vijver DA; van Loenen FB; Osterhaus AD; Remeijer L; Verjans GM
    J Infect Dis; 2013 Nov; 208(9):1359-65. PubMed ID: 23901090
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fluorosubstitution and 7-alkylation as prospective modifications of biologically active 6-aryl derivatives of tricyclic acyclovir and ganciclovir analogues.
    Ostrowski T; Golankiewicz B; De Clercq E; Balzarini J
    Bioorg Med Chem; 2005 Mar; 13(6):2089-96. PubMed ID: 15727862
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro and in vivo antiherpetic effects of (1R,2R)-1-(5'-methylful-3'-yl)propane-1,2,3-triol.
    Sasaki K; Hayashi K; Matsuya Y; Sugimoto K; Lee JB; Kurosaki F; Hayashi T
    J Nat Med; 2016 Apr; 70(2):217-24. PubMed ID: 26763002
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CRISPR/Cas9-mediated genome editing of the thymidine kinase gene in a clinical HSV-1 isolate identifies F289S as novel acyclovir-resistant mutation.
    Zheng S; Verjans GMGM; Evers A; van den Wittenboer E; Tjhie JHT; Snoeck R; Wiertz EJHJ; Andrei G; van Kampen JJA; Lebbink RJ
    Antiviral Res; 2024 Aug; 228():105950. PubMed ID: 38944159
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Isolation of drug resistant mutants of varicella-zoster virus: cross resistance of acyclovir resistant mutants with phosphonoacetic acid and bromodeoxyuridine.
    Shiraki K; Ogino T; Yamanishi K; Takahashi M
    Biken J; 1983 Mar; 26(1):17-23. PubMed ID: 6312958
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sensitivity of monkey B virus (Cercopithecine herpesvirus 1) to antiviral drugs: role of thymidine kinase in antiviral activities of substrate analogs and acyclonucleosides.
    Focher F; Lossani A; Verri A; Spadari S; Maioli A; Gambino JJ; Wright GE; Eberle R; Black DH; Medveczky P; Medveczky M; Shugar D
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2028-34. PubMed ID: 17438061
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Palladium(II) binding to N(7) of acyclovir: DNA interaction and herpes simplex virus (HSV-1) inhibitory activity.
    Gómez-Segura J; Caballero S; Moreno V; Prieto MJ; Bosch A
    J Inorg Biochem; 2009 Jan; 103(1):128-34. PubMed ID: 19022504
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Penciclovir is a potent inhibitor of feline herpesvirus-1 with susceptibility determined at the level of virus-encoded thymidine kinase.
    Hussein IT; Menashy RV; Field HJ
    Antiviral Res; 2008 Jun; 78(3):268-74. PubMed ID: 18325606
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of HSV-1 infection with immunoglobulin or acyclovir: comparison of their effects on viral spread, latency, and reactivation.
    LeBlanc RA; Pesnicak L; Godleski M; Straus SE
    Virology; 1999 Sep; 262(1):230-6. PubMed ID: 10489356
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relevance of non-synonymous thymidine kinase mutations for antiviral resistance of recombinant herpes simplex virus type 2 strains.
    Brunnemann AK; Hoffmann A; Deinhardt-Emmer S; Nagel CH; Rose R; Fickenscher H; Sauerbrei A; Krumbholz A
    Antiviral Res; 2018 Apr; 152():53-57. PubMed ID: 29427675
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of anise oil, dwarf-pine oil and chamomile oil against thymidine-kinase-positive and thymidine-kinase-negative herpesviruses.
    Koch C; Reichling J; Kehm R; Sharaf MM; Zentgraf H; Schneele J; Schnitzler P
    J Pharm Pharmacol; 2008 Nov; 60(11):1545-50. PubMed ID: 18957177
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The synergistic effects of betulin with acyclovir against herpes simplex viruses.
    Gong Y; Raj KM; Luscombe CA; Gadawski I; Tam T; Chu J; Gibson D; Carlson R; Sacks SL
    Antiviral Res; 2004 Nov; 64(2):127-30. PubMed ID: 15498608
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and antiviral evaluation of 1-O-hexadecylpropanediol-3-P-acyclovir: efficacy against HSV-1 infection in mice.
    Beadle JR; Kini GD; Aldern KA; Gardner MF; Wright KN; Rybak RJ; Kern ER; Hostetler KY
    Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):471-9. PubMed ID: 10772728
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential mutation patterns in thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 clones passaged in the presence of acyclovir or penciclovir.
    Suzutani T; Ishioka K; De Clercq E; Ishibashi K; Kaneko H; Kira T; Hashimoto K; Ogasawara M; Ohtani K; Wakamiya N; Saijo M
    Antimicrob Agents Chemother; 2003 May; 47(5):1707-13. PubMed ID: 12709344
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thymidine kinase with altered substrate specificity of acyclovir resistant varicella-zoster virus.
    Shiraki K; Ogino T; Yamanishi K; Takahashi M
    Biken J; 1986 Mar; 29(1):7-10. PubMed ID: 3022711
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Molecular genetic analysis of thimidine kinase from herpes simplex virus type 1].
    Gus'kova AA; Zagurnyĭ AV; Skoblov MIu; Baranova AV; Andronova VL; Iankovskiĭ NK; Galegov GA; Skoblov IuS
    Mol Biol (Mosk); 2005; 39(1):155-8. PubMed ID: 15773560
    [No Abstract]   [Full Text] [Related]  

  • 58. Resistance of herpes simplex virus type 1 to acyclovir: thymidine kinase gene mutagenesis study.
    Frobert E; Ooka T; Cortay JC; Lina B; Thouvenot D; Morfin F
    Antiviral Res; 2007 Feb; 73(2):147-50. PubMed ID: 16970995
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutations close to functional motif IV in HSV-1 UL5 helicase that confer resistance to HSV helicase-primase inhibitors, variously affect virus growth rate and pathogenicity.
    Biswas S; Tiley LS; Zimmermann H; Birkmann A; Field HJ
    Antiviral Res; 2008 Oct; 80(1):81-5. PubMed ID: 18539344
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Profile of anti-herpetic action of ASP2151 (amenamevir) as a helicase-primase inhibitor.
    Yajima M; Yamada H; Takemoto M; Daikoku T; Yoshida Y; Long T; Okuda T; Shiraki K
    Antiviral Res; 2017 Mar; 139():95-101. PubMed ID: 28027917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.